Navigation Links
NicOx Reports First Quarter 2008 Financial Results
Date:5/14/2008

. These expenses also included structural costs such as leases, property service charges and maintenance costs (excluding structural costs related to research and development activities), legal and accounting fees and other external administrative costs. Selling expenses reached euro 0.8 million during the three months ended March 31, 2008 and correspond to the market analysis activities for naproxcinod, as well as the business development and communication activities of the Company. On March 31, 2008, the Company employed 35 people in its selling, general, and administrative departments, compared to 28 people on March 31, 2007.

Other income

In the three months ended March 31, 2008, other income amounted to euro 1.6 million, compared to euro 1.9 million in the same period of 2007. Other income corresponds to the operational subsidies from the research tax credits which were previously deducted from research and development expenses until December 31, 2007.

Operating result

The operating loss amounted to euro 14.5 million during the first quarter of 2008, compared to an operating profit of euro 0.5 million in the first quarter of 2007. This situation is explained primarily by the strong increase in operating expenses during the first quarter of 2008 and by the considerable decrease in revenues recognized during the period as indicated above.

Other results

Net financial income amounted to euro 1.6 million during the first quarter of 2008, compared to euro 1.4 million during the three months ended March 31, 2007.

The income tax expense incurred by NicOx during the first quarter of 2008 relates principally to its Italian subsidiary and amounts to euro 0.1 million, compared to euro 0.1 million during the same period of 2007.

Net result

The net loss reached euro 13 million during the first quarter of 2008, compared to a net profit of euro 1.8 million in the three months ended March 31, 2007. As indicated above
'/>"/>

SOURCE NicOx S.A.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. NicOx Announces U.S. Phase 2a Results for PF-03187207 and Gives an Update on Continuing NO-prostaglandin Program
2. Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year
3. IRIDEX Reports First Quarter 2008 Financial Results
4. Cardiome Reports First Quarter Results
5. MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results
6. Health Plan Execs Receive Smaller Bonuses as Companies Push Performance-Based Pay, HPW Reports; Hanway Tops Others in Total Compensation
7. TorreyPines Therapeutics Reports First Quarter 2008 Financial Results and Accomplishments
8. Med-Emerg International Inc. reports improved income from continuing operations
9. NxStage Medical Reports First Quarter 2008 Results
10. MAP Pharmaceuticals Reports First Quarter of 2008 Financial Results
11. ULURU Inc. Reports First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... August 31, 2015 , ... CareSource, a nonprofit Ohio-based health ... this capacity, Michael will provide strategic leadership for CareSource’s marketing, branding, corporate communications ... that have contributed to the company’s rapid growth. As the CareSource business model ...
(Date:8/31/2015)... , ... August 31, 2015 , ... The Bay ... to Veterans residing across southwest Florida by hiring more doctors and nurses and expanding ... of expanded services. , In early July, Dr. Anthony Jabre was selected to lead ...
(Date:8/31/2015)... ... 01, 2015 , ... Neuropsychiatric Disease and Treatment ... transcranial near-infrared laser phototherapy ”. , As corresponding author Dr Theodore Henderson says ... - with mostly palliative treatments only - and now we have shown real ...
(Date:8/31/2015)... ... 31, 2015 , ... Since 1946, the doctors and staff at Clifton Dental ... a patient arrives at the office, the staff will make them feel welcome and ... patient to create a complete dental treatment plan that is unique to each smile! ...
(Date:8/31/2015)... ... ... With the FCPX LUT Soft pack from Pixel Film Studios, editors can quickly and easily ... mathematical formula for modifying an image. The LUT changes every pixel's color to the corresponding ... FCPX LUT Soft requires Final Cut Pro X 10.2 or newer. , By manipulating ...
Breaking Medicine News(10 mins):Health News:CareSource Names Vice President, Marketing and Corporate Communications 2Health News:Neurosurgeon Selected to Lead Growing Spine Care Program 2Health News:Neurosurgeon Selected to Lead Growing Spine Care Program 3Health News:Near-Infrared Laser Phototherapy for Brain Injury published by Dove Medical Press 2Health News:Near-Infrared Laser Phototherapy for Brain Injury published by Dove Medical Press 3Health News:NJ Top Dentists Presents, Clifton Dental Associates! 2Health News:Pixel Film Studios, FCPX Plugin Developer, Releases FCPX LUT Soft 2
... Diffusion,Pharmaceuticals LLC, a clinical-stage drug development company,commercializing ... enhances oxygen diffusion, today announced the results of ... candidate, trans sodium crocetinate (TSC). In,addition, the company ... the proceeds of which will support the company,s ...
... eases the depression that often accompanies the condition, ... -- For rheumatoid arthritis sufferers whose painful illness ... of an age-old technique already embraced by millions ... a half-year exposure to meditation techniques helped patients ...
... Region 5 today told Park Ridge-Niles School District 64,that ... Park,Ridge in mid- September shows no PCB risk to ... the district superintendent, EPA said it had found no,detectable ... and wipe,samples were taken as a precaution because PCBs ...
... Sept. 28 - About a third of American,adults take ... nearly every,case, the goal is better health, even though ... absence of benefit is one thing, but the presence ... of the National Cancer,Institute concluded that there was an ...
... profile of a particular lung tumor can help clinicians ... try first. , A new study led by researchers ... Duke Institute for Genome Sciences & Policy (IGSP) found ... widely used chemotherapy drugs. , We were able ...
... Campaign for Tobacco-Free ... ... V. Corr, Executive Director, Campaign for,Tobacco-Free Kids: Last night, the U.S. ... for a 61-cent-per-pack increase in the,federal cigarette tax to help fund the ...
Cached Medicine News:Health News:Diffusion Pharmaceuticals Announces Results of Phase I Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC) and Completion of a $4.5 Million Private Placement 2Health News:Diffusion Pharmaceuticals Announces Results of Phase I Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC) and Completion of a $4.5 Million Private Placement 3Health News:Diffusion Pharmaceuticals Announces Results of Phase I Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC) and Completion of a $4.5 Million Private Placement 4Health News:Meditation May Help Rheumatoid Arthritis Sufferers 2Health News:Meditation May Help Rheumatoid Arthritis Sufferers 3Health News:Meditation May Help Rheumatoid Arthritis Sufferers 4Health News:EPA Says Follow-Up Sampling Shows No PCB Risk at Park Ridge Elementary School 2Health News:Excessive Multivitamin Use May Raise Risk for Prostate Cancer, from Harvard Men's Health Watch 2Health News:Genomic profiling of lung tumors helps doctors choose most effective treatment 2Health News:Genomic profiling of lung tumors helps doctors choose most effective treatment 3Health News:President Bush Should Protect Kids, Not Big Tobacco By Signing Bill to Increase Cigarette Tax, Fund SCHIP 2
(Date:8/31/2015)... 31, 2015  Asterias Biotherapeutics, Inc. (NYSE MKT: ... field of regenerative medicine, today announced that the ... Chicago -based Rush University Medical Center in ... escalating doses of AST-OPC1 (oligodendrocyte progenitor cells) in ... cervical spinal cord injury (SCI). This represents the ...
(Date:8/31/2015)... 2015   BioLife Solutions , Inc. (NASDAQ: ... marketer of proprietary clinical grade cell and tissue ... media and a related cloud hosted ... smart shippers ("BioLife" or the "Company"), today ... biopharmaceutical company focused on developing and commercializing novel ...
(Date:8/28/2015)... , Aug. 28, 2015  With the heroin ... reaching deadlier heights, Jacksonville -based Lakeview ... Hemphill is helping to explain why fentanyl is ... approximately 40 to 50 times more potent than pharmaceutical ... users as heroin, the risk of death skyrockets. ...
Breaking Medicine Technology:Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 2BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 3BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 4BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 5Lakeview Health's Dr. Philip Hemphill Explains Why Heroin Addicts Are Now Dying of Fentanyl Overdoses 2
... (OTCQX: DATA), a technology and services company focused on global ... its Vice President of Research and Development, Chris Wilke, has ... 2009 Society for Clinical Data Management (SCDM) Annual Conference which ... Mr. Wilke will be discussing Is 100% EDC Realistic? ...
... ThermalTherapeutic Systems, Inc., developers of a highly ... today the completion of $2.75 Million Series A ... funding by the Pittsburgh Life Sciences Greenhouse, and ... investments by the Pittsburgh Life Sciences Greenhouse and ...
Cached Medicine Technology:DATATRAK to Present at 2009 SCDM Annual Conference 2DATATRAK to Present at 2009 SCDM Annual Conference 3ThermalTherapeutic Systems Completes $2.75 Million Series A Financing With Originate Ventures 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: